论文部分内容阅读
目的观察胺碘酮治疗心力衰竭合并心律失常的临床效果。方法选取医院2013年1月-2015年9月收治的心力衰竭合并心律失常的患者40例,随机分为研究组和对照组各20例,研究组采取胺碘酮治疗,对照组采取常规对症处理,比较2组治疗效果。结果研究组血压、心率、LVEF、E/A、FS等指标改善情况较对照组明显,差异有统计学意义(P<0.05)。2组不良反应发生率比较差异无统计学意义(P>0.05)。结论采取胺碘酮治疗心力衰竭合并心律失常效果显著,不良反应少,改善患者心功能,值得临床推广应用。
Objective To observe the clinical effect of amiodarone in the treatment of heart failure with arrhythmia. Methods Forty patients with heart failure and arrhythmia admitted from January 2013 to September 2015 in our hospital were randomly divided into study group (20 cases) and control group (20 cases). The study group was treated with amiodarone, while the control group was treated with routine symptomatic treatment , Compare two groups of treatment effect. Results The improvement of blood pressure, heart rate, LVEF, E / A and FS in the study group were more significant than those in the control group (P <0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P> 0.05). Conclusion Amiodarone is effective in treating heart failure complicated with arrhythmia, with fewer adverse reactions and improvement of cardiac function. It is worthy of clinical application.